BioCentury
ARTICLE | Company News

Memcine, Spotlight Innovation deal

July 27, 2015 7:00 AM UTC

Spotlight acquired an 82% stake in Memcine, which is developing its Immunoplex vaccine platform technology to use the body’s innate immuno-targeting system to stimulate the immune response following v...